Global Cannabidiol (CBD) Edibles Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Cannabidiol (CBD) Edibles Market Research Report 2024
Due to their extraordinary therapeutic effects, cannabidiol (CBD) edibles are beneficial to users in a variety of ways. These CBD sweets, which come in a number of flavours and textures, provide hemp-based chemicals or cannabis to the body for stress and depression alleviation. They are also termed as cannabis-infused goods.
According to MRA Research’s new survey, global Cannabidiol (CBD) Edibles market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cannabidiol (CBD) Edibles market research.
Key companies engaged in the Cannabidiol (CBD) Edibles industry include Isodiol International, Canopy Growth Corporation, Aurora Cannabis, MGC Pharma, Creso Pharma, Cronos Group, Chill Brands, Curaleaf and Green Thumb Industries, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of Cannabidiol (CBD) Edibles were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole Cannabidiol (CBD) Edibles market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cannabidiol (CBD) Edibles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Isodiol International
Canopy Growth Corporation
Aurora Cannabis
MGC Pharma
Creso Pharma
Cronos Group
Chill Brands
Curaleaf
Green Thumb Industries
Tilray
Ecofibre Limited
ENDOCA
Elixinol
Folium Biosciences
NuLeaf Naturals
PharmaHemp
Happy Hemp
Purekana
CV Sciences
CHARLOTTE’S WEB
Colorado Botanicals
PLUS Products Wonders
Balance CBD
Segment by Type
Beverage
Candy
Biscuit
Cake
Others
Supermarket
Convenience Store
Hospital
Online Sale
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cannabidiol (CBD) Edibles report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRA Research’s new survey, global Cannabidiol (CBD) Edibles market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cannabidiol (CBD) Edibles market research.
Key companies engaged in the Cannabidiol (CBD) Edibles industry include Isodiol International, Canopy Growth Corporation, Aurora Cannabis, MGC Pharma, Creso Pharma, Cronos Group, Chill Brands, Curaleaf and Green Thumb Industries, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of Cannabidiol (CBD) Edibles were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole Cannabidiol (CBD) Edibles market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cannabidiol (CBD) Edibles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Isodiol International
Canopy Growth Corporation
Aurora Cannabis
MGC Pharma
Creso Pharma
Cronos Group
Chill Brands
Curaleaf
Green Thumb Industries
Tilray
Ecofibre Limited
ENDOCA
Elixinol
Folium Biosciences
NuLeaf Naturals
PharmaHemp
Happy Hemp
Purekana
CV Sciences
CHARLOTTE’S WEB
Colorado Botanicals
PLUS Products Wonders
Balance CBD
Segment by Type
Beverage
Candy
Biscuit
Cake
Others
Segment by Application
Supermarket
Convenience Store
Hospital
Online Sale
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cannabidiol (CBD) Edibles report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source